Stephen Basso - Net Worth and Insider Trading
Stephen Basso Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen Basso owns 2 companies in total, including Inozyme Pharma Inc (INZY) , and Innoviva Inc (INVA) .
Click here to see the complete history of Stephen Basso’s form 4 insider trades.
Insider Ownership Summary of Stephen Basso
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INZY | Inozyme Pharma Inc | 2020-07-23 | Senior Vice President & Finance |
INVA | Innoviva Inc | 2023-08-21 | Chief Financial Officer |
Stephen Basso Trading Performance
Stephen Basso Ownership Network
Stephen Basso Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Stephen Basso is the Senior Vice President & Finance of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Stephen Basso made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Stephen Basso Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen Basso. You might contact Stephen Basso via mailing address: C/o Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston Ma 02210.